Stock screenerAll disclosures →
EDGAR →
GLUE
Conviction 100HealthcareScan · Thu, Jun 25, 2026GLUE$21.67+3.91%
ResistanceSupportVol 14Insider sell3
2
2
Vol MA14 1.67M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price21.67
Change+3.91%
Gap+0.65%
Rel volume4.11×
Avg volume1.47M
Avg $ vol27.97M
SMA 2018.39
SMA 5018.90
SMA 20016.15
Price vs 50+14.62%
Price vs 200+34.12%
MA stackbullish
50/200 cross—
Supertrendup · 17.31
RSI (14)70
MACD hist0.47
MACD crossbull · 6d
Stoch %K / %D90 / 87
ADX (14)26
+DI / −DI31 / 10
RSI divergence—
MACD divergenceBullish
ATR %+6.09%
ADR %6.95%
52w high25.31
52w low4.19
From 52w high-14.40%
Above 52w low+417.06%
New 52w highNo
SqueezeOff
Bollinger width32.11%
%B1.05
Donchian pos89.74%
Donchian high22.30
Donchian low16.11
AVWAP (52w high)19.35
vs AVWAP high+11.96%
AVWAP (52w low)15.68
vs AVWAP low+38.14%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d4.11×
Avg vol (14d)1.67M
Avg vol (20d)1.47M
Avg $ vol (20d)27.97M
Market cap1.83B
RS 3m (vs SPY)+29.39%
RS 6m (vs SPY)+26.43%
RS line new highNo
Trend template8/8
Technical rank89.9
1 week+17.68%
1 month+12.84%
3 months+37.91%
6 months+33.82%
1 year+357.07%
YTD+41.51%
P/E-47.38
P/B3.51
P/S14.80
P/FCF-66.56
EPS-2.96
Div yield—
ROE-7.40%
ROA-5.24%
Debt/Eq—
Current9.54
EV/EBITDA—
Gross margin—
Net margin-31.23%
Rev growth63.54%
EPS growth46.87%
Price target33.50
Target upside54.63%
Analyst ratingBuy
Institutional105.94%
Ent. value1.67B
Revenue4.21M
Net income-44.5M
Gross profit—
Free cash flow-27.5M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out84.48M
Employees161
ListedThu, Jun 24, 2021
Free float49.32M
Float %75.7%
Short interest16.01M
Days to cover19.2d
Short volume63.0%
Squeeze score95 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.25 · 3 est
Last EPS vs est−$0.45 vs −$0.28
Last surprise-60.7% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank89.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance21.00
Support16.77
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GLUE
No recent disclosed trades by Congress in GLUE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GLUE · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Janku Filip Chief Medical Officer · Common Stock · 2026-06-24 | Sell | 30K | $643K | 2026-06-24 | 2026-06-25 |
Janku Filip Chief Medical Officer · Common Stock · 2026-06-24 | Exercise | 30K | $227K | 2026-06-24 | 2026-06-25 |
Janku Filip Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-24 | Exercise | 30K | — | 2026-06-24 | 2026-06-25 |
Janku Filip Chief Medical Officer · Common Stock · 2026-06-23 | Sell | 11.85K | $240K | 2026-06-23 | 2026-06-25 |
Champoux Jennifer Chief Operating Officer · Common Stock · 2026-06-23 | Exercise | 2.17K | $9K | 2026-06-23 | 2026-06-25 |
Janku Filip Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-23 | Exercise | 6K | — | 2026-06-23 | 2026-06-25 |
Townson Sharon Chief Scientific Officer · Common Stock · 2026-06-23 | Exercise | 3K | $18K | 2026-06-23 | 2026-06-25 |
Townson Sharon Chief Scientific Officer · Common Stock · 2026-06-23 | Sell | 3K | $60K | 2026-06-23 | 2026-06-25 |
Champoux Jennifer Chief Operating Officer · Common Stock · 2026-06-23 | Sell | 2.17K | $44K | 2026-06-23 | 2026-06-25 |
Townson Sharon Chief Scientific Officer · Stock Option (Right to Buy) · 2026-06-23 | Exercise | 3K | — | 2026-06-23 | 2026-06-25 |
SEC filings
EDGAR filings in GLUE · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.